130683569	130683569	CD	B-NP	O
|	|	NN	I-NP	O
ZMC	ZMC	NN	I-NP	O
|	|	NN	I-NP	O
35220680	35220680	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
9847355	9847355	CD	B-NP	O
|	|	CC	I-NP	O
1/13/2004	1/13/2004	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	O
Congestive	Congestive	NNP	I-NP	O
Heart	Heart	NNP	I-NP	O
Failure	Failure	NNP	I-NP	O
|	|	NNP	I-NP	O
|	|	NNP	I-NP	O
DIS	DIS	NNP	I-NP	O
|	|	NNP	I-NP	O
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
4/25/2004	4/25/2004	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Discharge	Discharge	NNP	B-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
10/7/2004	10/7/2004	CD	B-NP	O
******	******	SYM	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
ORDERS	ORDERS	NN	I-NP	O
******	******	SYM	B-NP	O
TUBVILLE	TUBVILLE	NN	I-NP	O
,	,	,	O	O
HIRAM	HIRAM	NNP	B-NP	O
E	E	NNP	I-NP	O
678-98-88-9	678-98-88-9	CD	I-NP	O
Lin	Lin	NNP	I-NP	O
Arb	Arb	NNP	I-NP	O
Tole	Tole	NNP	I-NP	O
Service	Service	NNP	I-NP	O
:	:	:	O	O
MED	MED	NNP	B-NP	O
DISCHARGE	DISCHARGE	NNP	I-NP	O
PATIENT	PATIENT	NNP	I-NP	O
ON	ON	NNP	I-NP	O
:	:	:	O	O
5/24/04	5/24/04	CD	B-NP	O
AT	AT	NN	I-NP	O
04	04	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
PM	PM	NN	I-NP	O
CONTINGENT	CONTINGENT	NN	I-NP	O
UPON	UPON	NN	I-NP	O
HO	HO	NN	I-NP	O
evaluation	evaluation	NN	I-NP	O
WILL	WILL	MD	B-VP	O
D/C	D/C	NNP	B-NP	O
ORDER	ORDER	NNP	I-NP	O
BE	BE	NNP	I-NP	O
USED	USED	NNP	I-NP	O
AS	AS	NNP	I-NP	O
THE	THE	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
SUMMARY	SUMMARY	NNP	I-NP	O
:	:	:	O	O
YES	YES	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
LARONDA	LARONDA	NNP	B-NP	O
,	,	,	O	O
CHUNG	CHUNG	NNP	B-NP	O
ZACHERY	ZACHERY	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
CODE	CODE	NNP	I-NP	O
STATUS	STATUS	NNP	I-NP	O
:	:	:	O	O
Full	Full	JJ	B-NP	O
code	code	NN	I-NP	O
DISPOSITION	DISPOSITION	NN	I-NP	O
:	:	:	O	O
Home	Home	NN	B-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
ACETYLSALICYLIC	ACETYLSALICYLIC	NN	B-NP	O
ACID	ACID	NN	I-NP	O
325	325	CD	B-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
Override	Override	NNP	I-NP	O
Notice	Notice	NNP	I-NP	O
:	:	:	O	O
Override	Override	NNP	B-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
5/24/04	5/24/04	CD	B-NP	O
by	by	IN	B-PP	O
HALLINGER	HALLINGER	NN	B-NP	O
,	,	,	O	O
DONN	DONN	NN	B-NP	B-protein
,	,	,	O	O
M.D.	M.D.	NN	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
COUMADIN	COUMADIN	NN	B-NP	O
PO	PO	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
70391390	70391390	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
ASPIRIN	ASPIRIN	NNP	B-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
aware	aware	JJ	B-ADJP	O
,	,	,	O	O
will	will	MD	B-VP	O
follow	follow	VB	I-VP	O
.	.	.	O	O

Pt	Pt	NN	B-NP	O
has	have	VBZ	B-VP	O
tolerated	tolerate	VBN	I-VP	O
this	this	DT	B-NP	O
regimen	regimen	NN	I-NP	O
DIGOXIN	DIGOXIN	NN	I-NP	O
0.125	0.125	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
Override	Override	NNP	I-NP	O
Notice	Notice	NNP	I-NP	O
:	:	:	O	O
Override	Override	NNP	B-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
5/24/04	5/24/04	CD	B-NP	O
by	by	IN	B-PP	O
ROXBURGH	ROXBURGH	NN	B-NP	O
,	,	,	O	O
BENNETT	BENNETT	NN	B-NP	O
,	,	,	O	O
M.D.	M.D.	NN	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
SYNTHROID	SYNTHROID	NN	B-NP	O
PO	PO	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
31073136	31073136	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
DIGOXIN	DIGOXIN	NNP	B-NP	O
&	&	CC	I-NP	O
LEVOTHYROXINE	LEVOTHYROXINE	NNP	I-NP	O
SODIUM	SODIUM	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
aware	aware	JJ	B-ADJP	O
.	.	.	O	O

will	will	MD	B-VP	O
follow	follow	VB	I-VP	O
ENALAPRIL	ENALAPRIL	NNP	B-NP	O
MALEATE	MALEATE	NNP	I-NP	O
20	20	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QAM	QAM	NNP	I-NP	O
LASIX	LASIX	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
FUROSEMIDE	FUROSEMIDE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
80	80	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QAM	QAM	NNP	I-NP	O
Alert	Alert	NNP	I-NP	O
overridden	overridden	JJ	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
9/9/04	9/9/04	CD	B-NP	O
by	by	IN	B-PP	O
BARFIELD	BARFIELD	NN	B-NP	O
,	,	,	O	O
LAVERN	LAVERN	NN	B-NP	O
,	,	,	O	O
M.D.	M.D.	NN	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
LASIX	LASIX	NN	B-NP	O
PO	PO	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
22457342	22457342	CD	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
Pt	Pt	NN	I-NP	O
.	.	.	O	O

has	have	VBZ	O	O
a	a	DT	B-NP	O
POSSIBLE	POSSIBLE	NN	I-NP	O
allergy	allergy	NN	I-NP	O
to	to	TO	B-PP	O
Sulfa	Sulfa	NNP	B-NP	O
;	;	:	O	O
reaction	reaction	NN	B-NP	O
is	be	VBZ	B-VP	O
Unknown	Unknown	JJ	B-ADJP	O
.	.	.	O	O

Pt	Pt	NN	B-NP	O
.	.	.	O	O

has	have	VBZ	O	O
a	a	DT	B-NP	O
POSSIBLE	POSSIBLE	NN	I-NP	O
allergy	allergy	NN	I-NP	O
to	to	TO	B-PP	O
TRIMETHOPRIM/SULFAMETHOXAZOLE	TRIMETHOPRIM/SULFAMETHOXAZOLE	NN	B-NP	O
;	;	:	O	O
reaction	reaction	NN	B-NP	O
is	be	VBZ	B-VP	O
Unknown	Unknown	JJ	B-ADJP	O
.	.	.	O	O

Reason	Reason	NN	B-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
pt	pt	NN	B-NP	O
has	have	VBZ	B-VP	O
already	already	RB	I-VP	O
tolerated	tolerate	VBN	I-VP	O
med	me	VBN	I-VP	O
SYNTHROID	SYNTHROID	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
LEVOTHYROXINE	LEVOTHYROXINE	NNP	I-NP	O
SODIUM	SODIUM	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
100	100	CD	I-NP	O
MCG	MCG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
Alert	Alert	NNP	I-NP	O
overridden	overridden	JJ	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
5/24/04	5/24/04	CD	B-NP	O
by	by	IN	B-PP	O
GLADU	GLADU	NNP	B-NP	O
,	,	,	O	O
LEOPOLDO	LEOPOLDO	NNP	B-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
WARFARIN	WARFARIN	NNP	B-NP	O
&	&	CC	I-NP	O
LEVOTHYROXINE	LEVOTHYROXINE	NNP	I-NP	O
SODIUM	SODIUM	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
DIGOXIN	DIGOXIN	NNP	B-NP	O
&	&	CC	I-NP	O
LEVOTHYROXINE	LEVOTHYROXINE	NNP	I-NP	O
SODIUM	SODIUM	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
aware	aware	JJ	B-ADJP	O
.	.	.	O	O

will	will	MD	B-VP	O
follow	follow	VB	I-VP	O
COUMADIN	COUMADIN	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
SODIUM	SODIUM	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
6	6	CD	I-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
x1	x1	NN	I-NP	O
Starting	Start	VBG	B-VP	O
ON	ON	NN	B-NP	B-protein
3/5/04	3/5/04	CD	I-NP	I-protein
-LRB-	-LRB-	HYPH	B-NP	I-protein
8/25	8/25	CD	I-NP	I-protein
-RRB-	-RRB-	NNPS	I-NP	I-protein
Instructions	Instruction	NNPS	I-NP	O
:	:	:	O	O
ON	ON	NNP	B-NP	O
IN	IN	NNP	I-NP	O
EVENING	EVENING	NNP	I-NP	O
OF	OF	IN	B-PP	O
Food/Drug	Food/Drug	NNP	B-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
No	No	NNP	I-NP	O
high	high	JJ	I-NP	O
Vitamin-K	Vitamin-K	NN	I-NP	O
containing	contain	VBG	B-VP	O
foods	food	NNS	B-NP	O
Override	Override	NNP	I-NP	O
Notice	Notice	NNP	I-NP	O
:	:	:	O	O
Override	Override	NNP	B-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
5/24/04	5/24/04	CD	B-NP	O
by	by	IN	B-PP	O
KAYES	KAYES	NNP	B-NP	O
,	,	,	O	O
ASHLEY	ASHLEY	NNP	B-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
SYNTHROID	SYNTHROID	NN	B-NP	O
PO	PO	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
31073136	31073136	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
WARFARIN	WARFARIN	NNP	B-NP	O
&	&	CC	I-NP	O
LEVOTHYROXINE	LEVOTHYROXINE	NNP	I-NP	O
SODIUM	SODIUM	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
aware	aware	JJ	B-ADJP	O
.	.	.	O	O

will	will	MD	B-VP	O
follow	follow	VB	I-VP	O
Previous	Previous	JJ	B-NP	O
override	override	NN	I-NP	O
information	information	NN	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
5/24/04	5/24/04	CD	B-NP	O
by	by	IN	B-PP	O
LAURENO	LAURENO	NN	B-NP	O
,	,	,	O	O
CLEMENTE	CLEMENTE	NNP	B-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
ASPIRIN	ASPIRIN	NNP	B-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
aware	aware	JJ	B-ADJP	O
,	,	,	O	O
will	will	MD	B-VP	O
follow	follow	VB	I-VP	O
.	.	.	O	O

Pt	Pt	NN	B-NP	O
has	have	VBZ	B-VP	O
tolerated	tolerate	VBN	I-VP	O
this	this	DT	B-NP	O
regimen	regimen	NN	I-NP	B-protein
MVI	MVI	NN	I-NP	I-protein
THERAPEUTIC	THERAPEUTIC	NN	I-NP	I-protein
-LRB-	-LRB-	NN	I-NP	I-protein
THERAPEUTIC	THERAPEUTIC	NN	I-NP	I-protein
MULTIVITAMINS	MULTIVITAMINS	NN	I-NP	I-protein
-RRB-	-RRB-	HYPH	B-NP	I-protein
1	1	CD	I-NP	I-protein
TAB	TAB	NN	I-NP	I-protein
PO	PO	NN	I-NP	I-protein
QD	QD	NN	I-NP	I-protein
NEURONTIN	NEURONTIN	NN	I-NP	I-protein
-LRB-	-LRB-	NN	I-NP	I-protein
GABAPENTIN	GABAPENTIN	NN	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
200	200	CD	I-NP	I-protein
MG	MG	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
QPM	QPM	NNP	I-NP	I-protein
LISPRO	LISPRO	NNP	I-NP	I-protein
-LRB-	-LRB-	NNP	I-NP	I-protein
INSULIN	INSULIN	NNP	I-NP	I-protein
LISPRO	LISPRO	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Sliding	Sliding	NNP	I-NP	O
Scale	Scale	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
subcutaneously	subcutaneously	RB	B-NP	O
-RRB-	-RRB-	HYPH	I-NP	O
SC	SC	NN	I-NP	B-protein
AC	AC	NN	I-NP	I-protein
If	If	IN	B-SBAR	I-protein
BS	BS	NNP	B-NP	I-protein
is	be	VBZ	B-VP	O
less	less	JJR	B-NP	O
than	than	IN	I-NP	O
125	125	CD	I-NP	O
,	,	,	O	O
then	then	RB	B-ADVP	O
give	give	VB	B-VP	O
0	0	CD	B-NP	O
units	unit	NNS	I-NP	O
subcutaneously	subcutaneously	RB	B-ADVP	O
If	If	IN	B-SBAR	O
BS	BS	NNP	B-NP	O
is	be	VBZ	B-VP	O
125-150	125-150	CD	B-NP	O
,	,	,	O	O
then	then	RB	O	O
give	give	VB	B-VP	O
2	2	CD	B-NP	O
units	unit	NNS	I-NP	O
subcutaneously	subcutaneously	RB	B-ADVP	O
If	If	IN	B-SBAR	O
BS	BS	NNP	B-NP	O
is	be	VBZ	B-VP	O
151-200	151-200	CD	B-NP	O
,	,	,	O	O
then	then	RB	B-ADVP	O
give	give	VB	B-VP	O
3	3	CD	B-NP	O
units	unit	NNS	I-NP	O
subcutaneously	subcutaneously	RB	B-ADVP	O
If	If	IN	B-SBAR	O
BS	BS	NNP	B-NP	O
is	be	VBZ	B-VP	O
201-250	201-250	CD	B-NP	O
,	,	,	O	O
then	then	RB	B-ADVP	O
give	give	VB	B-VP	O
4	4	CD	B-NP	O
units	unit	NNS	I-NP	O
subcutaneously	subcutaneously	RB	B-ADVP	O
If	If	IN	B-SBAR	O
BS	BS	NNP	B-NP	O
is	be	VBZ	B-VP	O
251-300	251-300	CD	B-NP	O
,	,	,	O	O
then	then	RB	B-ADVP	O
give	give	VB	B-VP	O
6	6	CD	B-NP	O
units	unit	NNS	I-NP	O
subcutaneously	subcutaneously	RB	B-ADVP	O
If	If	IN	B-SBAR	O
BS	BS	NNP	B-NP	O
is	be	VBZ	B-VP	O
301-350	301-350	CD	B-NP	O
,	,	,	O	O
then	then	RB	B-ADVP	O
give	give	VB	B-VP	O
8	8	CD	B-NP	O
units	unit	NNS	I-NP	O
subcutaneously	subcutaneously	RB	B-ADVP	O
If	If	IN	B-SBAR	O
BS	BS	NNP	B-NP	O
is	be	VBZ	B-VP	O
351-400	351-400	CD	B-NP	O
,	,	,	O	O
then	then	RB	B-ADVP	O
give	give	VB	B-VP	O
10	10	CD	B-NP	O
units	unit	NNS	I-NP	O
subcutaneously	subcutaneously	RB	B-ADVP	O
and	and	CC	O	O
call	call	VB	B-VP	O
HO	HO	NN	B-NP	B-protein
Call	Call	NN	I-NP	I-protein
HO	HO	NN	I-NP	I-protein
if	if	IN	B-SBAR	O
BS	BS	NNP	B-NP	O
is	be	VBZ	B-VP	O
greater	great	JJR	B-ADJP	O
than	than	IN	B-PP	O
400	400	CD	B-NP	O
NEXIUM	NEXIUM	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
ESOMEPRAZOLE	ESOMEPRAZOLE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
20	20	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
LANTUS	LANTUS	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
INSULIN	INSULIN	NNP	I-NP	O
GLARGINE	GLARGINE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
77	77	CD	I-NP	O
UNITS	UNITS	NNP	I-NP	O
SC	SC	NNP	I-NP	O
QAM	QAM	NNP	I-NP	O
TOPROL	TOPROL	NNP	I-NP	O
XL	XL	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
METOPROLOL	METOPROLOL	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
SUST	SUST	NNP	I-NP	O
.	.	.	O	O

REL	REL	NN	B-NP	B-protein
.	.	.	O	O
-RRB-	-RRB-	NNP	B-NP	O
-RRB-	-RRB-	NNP	I-NP	O

25	25	CD	B-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
BID	BID	NNP	I-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Take	Take	NNP	I-NP	O
consistently	consistently	RB	B-ADVP	O
with	with	IN	B-PP	O
meals	meal	NNS	B-NP	O
or	or	CC	B-PP	O
on	on	IN	B-PP	O
empty	empty	JJ	B-NP	O
stomach	stomach	NN	I-NP	O
.	.	.	O	O

COUMADIN	COUMADIN	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
SODIUM	SODIUM	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
5	5	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QPM	QPM	NNP	I-NP	O
Starting	Starting	NNP	I-NP	O
ROUTINE	ROUTINE	NNP	I-NP	O
,	,	,	O	O
20	20	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
Standard	Standard	NNP	I-NP	O
Admin	Admin	NNP	I-NP	O
Time	Time	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
8/25	8/25	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
No	No	NNP	I-NP	O
high	high	JJ	I-NP	O
Vitamin-K	Vitamin-K	NN	I-NP	O
containing	contain	VBG	B-VP	O
foods	food	NNS	B-NP	O
Alert	Alert	NNP	B-NP	O
overridden	overridden	JJ	B-ADJP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
5/24/04	5/24/04	CD	B-NP	O
by	by	IN	B-PP	O
:	:	:	O	O
POTENTIALLY	POTENTIALLY	NNP	B-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
ASPIRIN	ASPIRIN	NNP	B-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
LEVOTHYROXINE	LEVOTHYROXINE	NNP	B-NP	O
SODIUM	SODIUM	NNP	I-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
md	md	NN	B-NP	O
aware	aware	JJ	B-ADJP	O
.	.	.	O	O

pt	pt	NN	B-NP	O
is	be	VBZ	B-VP	O
closely	closely	RB	I-VP	O
monitored	monitor	VBN	I-VP	O
.	.	.	O	O

DIET	DIET	NN	B-NP	O
:	:	:	O	O
House	House	NN	B-NP	O
/	/	SYM	B-NP	O
2	2	CD	I-NP	O
gm	gm	NN	I-NP	O
Na	Na	NN	I-NP	O
/	/	SYM	B-VP	O
ADA	ADA	NN	B-NP	O
1800	1800	CD	I-NP	O
cals/day	cals/day	NN	I-NP	O
/	/	SYM	B-NP	O
Low	Low	NN	I-NP	O
saturated	saturate	VBD	B-VP	O
fat	fat	JJ	B-NP	O
low	low	JJ	I-NP	O
cholesterol	cholesterol	NN	I-NP	O
ACTIVITY	ACTIVITY	NN	I-NP	O
:	:	:	O	O
Walking	Walk	VBG	B-VP	O
as	as	IN	B-SBAR	O
tolerated	tolerate	VBN	B-NP	O
FOLLOW	FOLLOW	NNP	I-NP	O
UP	UP	NNP	I-NP	O
APPOINTMENT	APPOINTMENT	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
S	S	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
:	:	:	O	O
Please	Please	NNP	B-NP	O
Call	Call	VB	B-VP	O
your	your	PRP$	B-NP	O
nurse	nurse	NN	I-NP	O
to	to	TO	B-VP	O
set	set	VB	I-VP	O
up	up	RP	B-PRT	O
INR	INR	NN	B-NP	B-protein
check	check	NN	I-NP	I-protein
on	on	IN	B-PP	O
monday	monday	NN	B-NP	O
.	.	.	O	O

11/21/04	11/21/04	CD	B-NP	O
,	,	,	O	O
Your	Your	PRP$	B-NP	O
primary	primary	JJ	I-NP	O
care	care	NN	I-NP	O
doctor	doctor	NN	I-NP	O
.	.	.	O	O

Please	Please	VB	B-VP	O
call	call	VB	I-VP	O
to	to	TO	I-VP	O
schedule	schedule	VB	I-VP	O
1-2	1-2	CD	B-NP	O
weeks	week	NNS	I-NP	O
,	,	,	O	O
Arrange	Arrange	NNP	B-NP	O
INR	INR	NNP	I-NP	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
drawn	draw	VBN	I-VP	O
on	on	IN	B-PP	O
1/2/04	1/2/04	CD	B-NP	O
with	with	IN	B-PP	O
f/u	f/u	NN	B-NP	O
INR	INR	NNP	B-NP	O
's	's	POS	B-NP	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
drawn	draw	VBN	I-VP	O
every	every	DT	B-NP	O
3	3	CD	I-NP	O
days	day	NNS	I-NP	O
.	.	.	O	O

INR	INR	NN	B-NP	O
's	's	POS	B-NP	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
followed	follow	VBN	I-VP	O
by	by	IN	B-PP	O
WH	WH	NN	B-NP	B-protein
CHF	CHF	NN	I-NP	I-protein
/	/	SYM	B-NP	O
Cards	Card	NNS	I-NP	O
nurse	nurse	NN	I-NP	O
ALLERGY	ALLERGY	NN	I-NP	O
:	:	:	O	O
Penicillins	Penicillins	NNP	B-NP	O
,	,	,	O	O
Cephalosporins	Cephalosporins	NNP	B-NP	O
,	,	,	O	O
Sulfa	Sulfa	NNP	B-NP	O
,	,	,	O	O
TRIMETHOPRIM/SULFAMETHOXAZOLE	TRIMETHOPRIM/SULFAMETHOXAZOLE	NNP	B-NP	O
,	,	,	O	O
TRIMETHOPRIM	TRIMETHOPRIM	NNP	B-NP	O
,	,	,	O	O
Codeine	Codeine	NNP	B-NP	O
ADMIT	ADMIT	NNP	I-NP	O
DIAGNOSIS	DIAGNOSIS	NNP	I-NP	O
:	:	:	O	O
Congestive	Congestive	JJ	B-NP	O
Heart	Heart	NN	I-NP	O
Failure	Failure	NN	I-NP	O
PRINCIPAL	PRINCIPAL	JJ	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
;	;	:	O	O
Responsible	Responsible	JJ	B-ADJP	O
After	After	IN	B-PP	O
Study	Study	NNP	B-NP	O
for	for	IN	B-PP	O
Causing	Causing	NNP	B-NP	O
Admission	Admission	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Congestive	Congestive	NNP	I-NP	O
Heart	Heart	NNP	I-NP	O
Failure	Failure	NNP	I-NP	O
OTHER	OTHER	NNP	I-NP	O
DIAGNOSIS	DIAGNOSIS	NNP	I-NP	O
;	;	:	O	O
Conditions	Condition	NNS	B-NP	O
,	,	,	O	O
Infections	Infection	NNS	B-NP	O
,	,	,	O	O
Complications	Complication	NNS	B-NP	O
,	,	,	O	O
affecting	affect	VBG	B-VP	O
Treatment/Stay	Treatment/Stay	NNP	B-NP	O
chf	chf	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
congestive	congestive	JJ	I-NP	O
heart	heart	NN	I-NP	O
failure	failure	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
diastolic	diastolic	JJ	I-NP	O
dysfunction	dysfunction	NN	I-NP	O
hypothyroidism	hypothyroidism	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
hypothyroidism	hypothyroidism	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
obesity	obesity	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
obesity	obesity	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
cri	cri	NN	I-NP	O
-LRB-	-LRB-	HYPH	B-NP	O
chronic	chronic	JJ	I-NP	O
renal	renal	JJ	I-NP	O
dysfunction	dysfunction	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
diabetes	diabete	VBZ	B-VP	O
-LRB-	-LRB-	NN	B-NP	B-protein
Type	Type	NN	I-NP	I-protein
2	2	CD	B-NP	I-protein
diabetes	diabete	NNS	I-NP	I-protein
-RRB-	-RRB-	HYPH	B-NP	I-protein
cad	cad	NN	I-NP	I-protein
-LRB-	-LRB-	HYPH	B-NP	I-protein
coronary	coronary	JJ	I-NP	O
artery	artery	NN	I-NP	O
disease	disease	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
s/p	s/p	NN	I-NP	O
cabg	cabg	NN	I-NP	O
x4	x4	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
S/P	S/P	NN	I-NP	O
cardiac	cardiac	JJ	B-ADJP	O
bypass	bypass	IN	B-PP	O
graft	graft	NN	B-NP	O
surgery	surgery	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
OPERATIONS	OPERATIONS	NNS	I-NP	O
AND	AND	CC	I-NP	O
PROCEDURES	PROCEDURES	NNS	I-NP	O
:	:	:	O	O
none	none	NN	B-NP	O
OTHER	OTHER	NN	I-NP	O
TREATMENTS/PROCEDURES	TREATMENTS/PROCEDURES	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
NOT	NOT	NNP	I-NP	O
IN	IN	NNP	I-NP	O
O.R.	O.R.	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Gentle	Gentle	NNP	I-NP	O
diuresis	diuresis	NN	I-NP	O
maximization	maximization	NN	I-NP	O
of	of	IN	B-PP	O
medications	medication	NNS	B-NP	O
BRIEF	BRIEF	NN	I-NP	O
RESUME	RESUME	NN	I-NP	O
OF	OF	IN	B-PP	O
HOSPITAL	HOSPITAL	JJ	B-NP	O
COURSE	COURSE	NN	I-NP	O
:	:	:	O	O
CC	CC	NN	B-NP	O
:	:	:	O	O
Increasing	Increasing	NNP	B-NP	O
DOE	DOE	NNP	I-NP	O
HPI	HPI	NNP	I-NP	O
:	:	:	O	O
81	81	CD	B-NP	O
y/o	y/o	NN	I-NP	O
F	F	NN	I-NP	O
with	with	IN	B-PP	O
h/o	h/o	NN	B-NP	O
CHF/CAD	CHF/CAD	NN	I-NP	O
s/p	s/p	NN	I-NP	O
CABG	CABG	NN	I-NP	O
,	,	,	O	O
with	with	IN	B-PP	O
worsening	worsen	VBG	B-VP	O
dyspnea	dyspnea	NN	B-NP	O
on	on	IN	B-PP	O
exertion	exertion	NN	B-NP	O
since	since	IN	B-PP	O
past	past	JJ	B-NP	O
2-3	2-3	CD	I-NP	O
days	day	NNS	I-NP	O
.	.	.	O	O

Pt	Pt	NN	B-NP	O
notes	note	VBZ	B-VP	O
weight	weight	NN	B-NP	O
inc	inc	NN	I-NP	O
to	to	TO	B-PP	O
157	157	CD	B-NP	O
,	,	,	O	O
and	and	CC	O	O
dropped	drop	VBD	B-VP	O
to	to	TO	B-PP	O
147	147	CD	B-NP	O
with	with	IN	B-PP	O
augmented	augmented	JJ	B-NP	O
diuresis	diuresis	NN	I-NP	O
.	.	.	O	O

Pt	Pt	NN	B-NP	O
target	target	NN	I-NP	O
weight	weight	NN	I-NP	O
=	=	SYM	B-VP	O
152-154	152-154	CD	B-NP	O
.	.	.	O	O

Pt	Pt	NN	B-NP	O
notes	note	VBZ	B-VP	O
no	no	DT	B-NP	O
change	change	NN	I-NP	O
in	in	IN	B-PP	O
baseline	baseline	NN	B-NP	O
orthopnea	orthopnea	NN	I-NP	O
,	,	,	O	O
but	but	CC	O	O
does	do	VBZ	B-VP	O
note	note	VB	I-VP	O
increasing	increase	VBG	B-NP	O
LEE	LEE	NN	I-NP	O
an	an	DT	B-NP	O
periorbital	periorbital	JJ	I-NP	O
edema	edema	NN	I-NP	O
.	.	.	O	O

Pt	Pt	NN	B-NP	O
has	have	VBZ	B-VP	O
fatigue	fatigue	NN	B-NP	O
even	even	RB	B-ADVP	O
with	with	IN	B-PP	O
minimal	minimal	JJ	B-NP	O
exertion	exertion	NN	I-NP	O
,	,	,	O	O
like	like	IN	B-PP	O
going	go	VBG	B-VP	O
to	to	TO	B-PP	O
bathroom	bathroom	NN	B-NP	O
.	.	.	O	O

Pt	Pt	NN	B-NP	O
had	have	VBD	B-VP	O
an	an	DT	B-NP	O
episode	episode	NN	I-NP	O
of	of	IN	B-PP	O
unstable	unstable	JJ	B-NP	O
AF	AF	NN	I-NP	O
with	with	IN	B-PP	O
CHF	CHF	NN	B-NP	B-protein
lat	lat	JJ	I-NP	O
month	month	NN	I-NP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
managed	manage	VBN	I-VP	O
as	as	IN	B-PP	O
an	an	DT	B-NP	O
outpt	outpt	NN	I-NP	O
with	with	IN	B-PP	O
med	me	VBN	B-NP	O
adjustment	adjustment	NN	I-NP	O
.	.	.	O	O

PMH	PMH	NN	B-NP	O
:	:	:	O	O
Afib	Afib	NN	B-NP	O
,	,	,	O	O
CHF	CHF	NN	B-NP	B-protein
,	,	,	O	O
CAD	CAD	NN	B-NP	B-protein
,	,	,	O	O
DM	DM	NN	B-NP	O
type	type	NN	I-NP	O
I	I	CD	I-NP	O
,	,	,	O	O
hearing	hear	VBG	B-VP	O
loss	loss	NN	B-NP	O
,	,	,	O	O
hypothyroidism	hypothyroidism	NN	B-NP	O
,	,	,	O	O
osteoporoisis	osteoporoisis	NN	B-NP	O
,	,	,	O	O
perihperal	perihperal	JJ	B-NP	O
neuropathy	neuropathy	NN	I-NP	O
.	.	.	O	O

PSH	PSH	NN	B-NP	O
:	:	:	O	O
s/p	s/p	NN	B-NP	O
CABG	CABG	NN	I-NP	O
.	.	.	O	O

A	A	DT	B-NP	O
:	:	:	O	O
Mild	Mild	NNP	B-NP	O
CHF	CHF	NNP	I-NP	O
,	,	,	O	O
here	here	RB	B-ADVP	O
for	for	IN	B-PP	O
treatment	treatment	NN	B-NP	O
maximization	maximization	NN	I-NP	O
.	.	.	O	O

HOSPITAL	HOSPITAL	JJ	B-NP	O
COURSE	COURSE	NN	I-NP	O
BY	BY	NN	I-NP	O
SYSTEM	SYSTEM	NN	I-NP	O
CV	CV	NN	I-NP	O
:	:	:	O	O
ischemia	ischemia	NN	B-NP	O
-	-	HYPH	O	O
ruled	rule	VBN	B-VP	O
out	out	RP	B-PRT	O
for	for	IN	B-PP	O
MI	MI	NN	B-NP	O
with	with	IN	B-PP	O
serial	serial	JJ	B-NP	B-protein
enzymes	enzyme	NNS	I-NP	I-protein
.	.	.	O	O

cont	cont	VB	B-VP	O
ACEI	ACEI	NNP	B-NP	O
,	,	,	O	O
Betablocker	Betablocker	NNP	B-NP	O
.	.	.	O	O

Lipid	Lipid	NN	B-NP	O
panel	panel	NN	I-NP	O
wnl	wnl	NN	I-NP	O
.	.	.	O	O

Pump-daily	Pump-daily	JJ	B-NP	O
weights	weight	NNS	I-NP	O
,	,	,	O	O
lasix	lasix	CD	B-NP	O
for	for	IN	B-PP	O
gentle	gentle	JJ	B-NP	O
diuresis	diuresis	NN	I-NP	O
of	of	IN	B-PP	O
goal	goal	NN	B-NP	O
500c	500c	CD	I-NP	O
-	-	HYPH	I-NP	O
1L	1L	NN	I-NP	O
net	net	NN	I-NP	O
negative	negative	JJ	B-ADJP	O
.	.	.	O	O

Rhythm	Rhythm	NN	B-NP	O
:	:	:	O	O
afib/Aflutter	afib/Aflutter	NN	B-NP	O
,	,	,	O	O
rate	rate	NN	B-NP	O
control	control	NN	I-NP	O
w/BBlocker	w/BBlocker	NNP	I-NP	O
Renal	Renal	NNP	I-NP	O
:	:	:	O	O
CRI	CRI	NN	B-NP	O
,	,	,	O	O
cr	cr	NN	B-NP	O
at	at	IN	B-PP	O
baseline	baseline	NN	B-NP	O
.	.	.	O	O

Normal	Normal	JJ	B-NP	O
,	,	,	I-NP	O
renal	renal	JJ	I-NP	O
dose	dose	NN	I-NP	O
meds	med	NNS	I-NP	O
FEN	FEN	NN	I-NP	O
:	:	:	O	O
follow	follow	JJ	B-NP	O
lytes/K/Mg	lytes/K/Mg	NN	I-NP	O
.	.	.	O	O

Diet-low	Diet-low	JJ	B-NP	O
fat/chol	fat/chol	NN	I-NP	O
.	.	.	O	O

Fluid	Fluid	NN	B-NP	O
restriction	restriction	NN	I-NP	O
to	to	TO	B-PP	O
2	2	CD	B-NP	O
L/day	L/day	NNP	I-NP	O
.	.	.	O	O

Endo	Endo	NNP	B-NP	O
:	:	:	O	O
Hypothyroid	Hypothyroid	NN	B-NP	O
-	-	HYPH	O	O
levoxyl	levoxyl	NN	B-NP	O
,	,	,	O	O
checked	check	VBD	B-VP	O
TSH	TSH	NN	B-NP	O
,	,	,	O	O
pending	pende	VBG	B-VP	O
at	at	IN	B-PP	O
time	time	NN	B-NP	O
of	of	IN	B-PP	O
disc	disc	NN	B-NP	O
harge	harge	NN	I-NP	O
.	.	.	O	O

DMtypeI	DMtypeI	NN	B-NP	O
-	-	HYPH	I-NP	O
lantus	lantus	NN	I-NP	O
77u	77u	NN	I-NP	O
qam	qam	NN	I-NP	O
,	,	,	O	O
lispro	lispro	NN	B-NP	O
SC	SC	NNP	I-NP	O
Heme	Heme	NNP	I-NP	O
:	:	:	O	O
Daily	Daily	RB	B-NP	O
PT/PTT	PT/PTT	NN	I-NP	B-protein
-	-	HYPH	B-NP	O
low	low	JJ	I-NP	O
INR	INR	NN	I-NP	O
.	.	.	O	O

Increased	Increase	VBN	B-NP	O
coumadin	coumadin	NN	I-NP	O
dose	dose	NN	I-NP	O
with	with	IN	B-PP	O
outpt	outpt	JJ	B-NP	O
follow-up	follow-up	NN	I-NP	O
.	.	.	O	O

Pt	Pt	NN	B-NP	O
returned	return	VBD	B-VP	O
home	home	NN	B-ADVP	O
in	in	IN	B-PP	O
improved	improve	VBN	B-NP	O
condition	condition	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
slight	slight	JJ	I-NP	O
change	change	NN	I-NP	O
in	in	IN	B-PP	O
outpatient	outpatient	NN	B-NP	O
medication	medication	NN	I-NP	O
regimen	regimen	NN	I-NP	O
-	-	HYPH	B-VP	O
namely	namely	RB	B-NP	O
Toprol	Toprol	NN	I-NP	O
XL	XL	NN	I-NP	O
incre	incre	VBP	B-VP	O
ased	ase	VBN	I-VP	O
to	to	TO	B-PP	O
25mg	25mg	NN	B-NP	O
BID	BID	NN	I-NP	O
,	,	,	O	O
digoxin	digoxin	NN	B-NP	O
0.125	0.125	CD	I-NP	O
mg	mg	NN	I-NP	O
QD	QD	NN	I-NP	O
.	.	.	O	O

ADDITIONAL	ADDITIONAL	JJ	B-NP	O
COMMENTS	COMMENTS	NNS	I-NP	O
:	:	:	O	O
If	If	IN	B-SBAR	O
you	you	PRP	B-NP	O
notice	notice	VBP	B-VP	O
rapid	rapid	JJ	B-NP	O
weight	weight	NN	I-NP	O
gain	gain	NN	I-NP	O
,	,	,	O	O
increasing	increase	VBG	B-VP	O
shortness	shortness	NN	B-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
,	,	,	O	O
chest	chest	NN	B-NP	O
pain	pain	NN	I-NP	O
,	,	,	O	O
light	light	JJ	B-NP	O
headedness	headedness	NN	I-NP	O
,	,	,	O	O
extreme	extreme	JJ	B-NP	O
fatigue	fatigue	NN	I-NP	O
,	,	,	O	O
or	or	CC	O	O
any	any	DT	B-NP	O
other	other	JJ	I-NP	O
symptom	symptom	NN	I-NP	O
concerning	concern	VBG	B-VP	O
to	to	TO	B-PP	O
you	you	PRP	B-NP	O
,	,	,	O	O
please	please	VB	B-VP	O
immediately	immediately	RB	I-VP	O
alert	alert	VB	I-VP	O
your	your	PRP$	B-NP	O
MD	MD	NN	I-NP	O
or	or	CC	O	O
present	present	JJ	B-ADJP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
nearest	near	JJS	I-NP	O
ED	ED	NN	I-NP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
CONDITION	CONDITION	NN	I-NP	O
:	:	:	O	O
Stable	Stable	JJ	B-NP	O
TO	TO	NN	I-NP	O
DO/PLAN	DO/PLAN	NN	I-NP	O
:	:	:	O	O
TSH	TSH	NN	B-NP	O
pending	pending	NN	I-NP	O
,	,	,	O	O
Check	Check	NNP	B-NP	O
INR	INR	NNP	I-NP	O
on	on	IN	B-PP	O
monday	monday	NN	B-NP	O
10/29/04	10/29/04	CD	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
dictated	dictated	JJ	I-NP	O
summary	summary	NN	I-NP	O
ENTERED	ENTERED	NNP	I-NP	O
BY	BY	NNP	I-NP	O
:	:	:	O	O
FAUDREE	FAUDREE	NNP	B-NP	O
,	,	,	O	O
CHRISTOPHER	CHRISTOPHER	NNP	B-NP	O
D.	D.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
FM34	FM34	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
5/24/04	5/24/04	CD	I-NP	O
@	@	SYM	B-NP	O
03	03	CD	I-NP	O
******	******	SYM	I-NP	O
END	END	NN	I-NP	O
OF	OF	IN	B-PP	O
DISCHARGE	DISCHARGE	NN	B-NP	O
ORDERS	ORDERS	NNS	I-NP	O
******	******	SYM	B-NP	O

